GLAND PHARMA
|
The Current P/S Ratio of GLAND PHARMA is 4.10.
Share Price | ₹1,426.6 | Apr 15,2025 |
Market Cap | ₹23,510.4 Cr | |
Sales-TTM | ₹5,729.0 Cr | TTM-Consolidated Results |
Price/Sales | 4.10x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹23,510.4 Cr] as on Apr 15,2025
(/) Sales [ ₹5,729.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.10x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay '4.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAND PHARMA !
The chart below summarizes the trend in P/S Ratio of GLAND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of GLAND PHARMA
PS Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.01x.
- GLAND PHARMA 's operated at median p/e ratio of 5.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 12.21x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does GLAND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAND PHARMA | 5,729.0 | 4.10 | 23,510.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.93 | 409,123.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.76 | 152,173.0 |
CIPLA LTD | 26,981.2 | 4.43 | 119,640.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.66 | 109,154.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.09 | 96,446.4 |
MANKIND PHARMA LTD | 11,641.0 | 8.60 | 100,170.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.00 | 88,971.2 |
LUPIN LTD | 22,001.6 | 4.18 | 91,863.2 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.13 | 65,929.7 |
ABBOTT INDIA LTD | 6,243.2 | 10.55 | 65,871.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.13x |
Max industry PS | 16.76x |
Median industry PS | 4.43x |
Average industry PS | 6.86x |
You may also like the below Video Courses